Financial Results : Care H1 2025 net profit up to SAR 165.3M; Q2 at SAR 79.9M

Care H1 2025 net profit up to SAR 165.3M; Q2 at SAR 79.9M

03/08/2025 Argaam Exclusive

View other reports

National Medical Care Co. (Care) reported net profit growth to SAR 165.3 million in H1 2025, compared to SAR 150.8 million in the prior-year period.



Financials (M)

Item 6m 2024 6m 2025 Change‬
Revenues 595.38 783.19 31.5 %
Gross Income 218.35 290.46 33.0 %
Operating Income 134.23 181.23 35.0 %
Net Income 150.78 165.31 9.6 %
Average Shares 44.85 44.85 -
Earnings Per Share before unusual items (Riyals) 2.72 3.69 35.7 %
EPS (Riyal) 3.36 3.69 9.6 %

H1 2025 revenue surged 31.5% year-on-year (YoY) reaching SAR 783.2 million, supported by a 40.4% YoY rise in total patients served on the back of strong key client referrals and the successful integration of newly acquired branches.

 

Cost optimization strategy supported margin expansions at the gross, operating, and EBITDA levels during the six-month period.

 

Meanwhile, lower net profit margin was recorded due to the one-off SAR 29 million Zakat provision reversal booked in H1 2024.

 

Care also noted higher general and administrative expenses and leased assets finance costs linked with the addition of Al Salam Hospital.



Current Quarter Comparison (M)

Compared With The
Item Q2 2024 Q2 2025 Change‬
Revenues 296.82 397.87 34.0 %
Gross Income 108.16 147.48 36.4 %
Operating Income 63.18 84.68 34.0 %
Net Income 69.50 79.94 15.0 %
Average Shares 44.85 44.85 -
Earnings Per Share before unusual items (Riyal) 1.26 1.78 41.9 %
EPS (Riyal) 1.55 1.78 15.0 %

Q2 2025 net profit rose 15% to SAR 79.9 million from SAR 69.5 million in Q2 2024.

 

On a sequential basis, net profit fell 6.4% from SAR 85.37 million in Q1 2025.

 

Shareholders’ equity, no minority interest, reached SAR 1.7 billion by June 30, 2025, compared to SAR 1.5 billion in a year earlier period.

 

Attached Documents

 

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.